139 related articles for article (PubMed ID: 37916706)
1. Redesign of radiotherapy for prostate cancer: a proposal for universal healthcare systems.
Beck da Silva Etges AP; de Lara LR; Sapper SL; Frankenberg Berger AV; Streck M; Zardo L; Linhares A; Nassif M; Zanotto A; Pereira Lima MN; Vargas R; Polanczyk CA
J Comp Eff Res; 2023 Dec; 12(12):e230023. PubMed ID: 37916706
[No Abstract] [Full Text] [Related]
2. The changing costs of radiation treatment for early prostate cancer in Ontario: a comparison between conventional and conformal external beam radiotherapy.
Poon I; Pintilie M; Potvin M; McGowan T
Can J Urol; 2004 Feb; 11(1):2125-32. PubMed ID: 15003151
[TBL] [Abstract][Full Text] [Related]
3. Comparison of COVID-19 hospitalization costs across care pathways: a patient-level time-driven activity-based costing analysis in a Brazilian hospital.
Cardoso RB; Marcolino MAZ; Marcolino MS; Fortis CF; Moreira LB; Coutinho AP; Clausell NO; Nabi J; Kaplan RS; Etges APBDS; Polanczyk CA
BMC Health Serv Res; 2023 Feb; 23(1):198. PubMed ID: 36829122
[TBL] [Abstract][Full Text] [Related]
4. Time-driven activity-based costing of low-dose-rate and high-dose-rate brachytherapy for low-risk prostate cancer.
Ilg AM; Laviana AA; Kamrava M; Veruttipong D; Steinberg M; Park SJ; Burke MA; Niedzwiecki D; Kupelian PA; Saigal C
Brachytherapy; 2016; 15(6):760-767. PubMed ID: 27720202
[TBL] [Abstract][Full Text] [Related]
5. Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysis.
Reddy D; van Son M; Peters M; Bertoncelli Tanaka M; Dudderidge T; Cullen E; Ho CLT; Hindley RG; Emara A; McCracken S; Orczyk C; Shergill I; Mangar S; Nigam R; Virdi J; Moore CM; Arya M; Shah TT; Winkler M; Emberton M; Falconer A; Belsey J; Ahmed HU
J Med Econ; 2023; 26(1):1099-1107. PubMed ID: 37656223
[TBL] [Abstract][Full Text] [Related]
6. Waiting for radiotherapy in Ontario.
Mackillop WJ; Fu H; Quirt CF; Dixon P; Brundage M; Zhou Y
Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):221-8. PubMed ID: 8083117
[TBL] [Abstract][Full Text] [Related]
7. Time-driven activity-based cost comparison of prostate cancer brachytherapy and intensity-modulated radiation therapy.
Dutta SW; Bauer-Nilsen K; Sanders JC; Trifiletti DM; Libby B; Lash DH; Lain M; Christodoulou D; Hodge C; Showalter TN
Brachytherapy; 2018; 17(3):556-563. PubMed ID: 29519605
[TBL] [Abstract][Full Text] [Related]
8. [Waiting times for cancer care in four most frequent cancers in several French regions in 2011 and 2012].
Pourcel G; Ledesert B; Bousquet PJ; Ferrari C; Viguier J; Buzyn A
Bull Cancer; 2013 Dec; 100(12):1237-50. PubMed ID: 24158562
[TBL] [Abstract][Full Text] [Related]
9. Time-driven activity-based costing as a strategy to increase efficiency: An analyses of interventional coronary procedures.
da Silva Etges APB; Cruz LN; Schlatter R; Neyeloff J; Cardoso RB; Kopittke L; Nunes AA; Neto JA; Nogueira JL; de Assis RM; Tobias JSP; Marin-Neto JA; Moreira LB; Polanczyk CA
Int J Health Plann Manage; 2022 Jan; 37(1):189-201. PubMed ID: 34505319
[TBL] [Abstract][Full Text] [Related]
10. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
Newell S; Jordan Z
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
[TBL] [Abstract][Full Text] [Related]
11. Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.
Hamdy FC; Donovan JL; Lane JA; Mason M; Metcalfe C; Holding P; Wade J; Noble S; Garfield K; Young G; Davis M; Peters TJ; Turner EL; Martin RM; Oxley J; Robinson M; Staffurth J; Walsh E; Blazeby J; Bryant R; Bollina P; Catto J; Doble A; Doherty A; Gillatt D; Gnanapragasam V; Hughes O; Kockelbergh R; Kynaston H; Paul A; Paez E; Powell P; Prescott S; Rosario D; Rowe E; Neal D
Health Technol Assess; 2020 Aug; 24(37):1-176. PubMed ID: 32773013
[TBL] [Abstract][Full Text] [Related]
12. Can the Adoption of Hypofractionation Guidelines Expand Global Radiotherapy Access? An Analysis for Breast and Prostate Radiotherapy.
Irabor OC; Swanson W; Shaukat F; Wirtz J; Mallum AA; Ngoma T; Elzawawy A; Nguyen P; Incrocci L; Ngwa W
JCO Glob Oncol; 2020 Apr; 6():667-678. PubMed ID: 32343628
[TBL] [Abstract][Full Text] [Related]
13. Insurance-based disparities in breast cancer treatment pathways in a universal healthcare system: a qualitative study.
Kesici Z; Yilmaz V
BMC Health Serv Res; 2023 Feb; 23(1):112. PubMed ID: 36732811
[TBL] [Abstract][Full Text] [Related]
14. The cost of metastatic prostate cancer using time-driven activity-based costing.
Vargas Alves RJ; Beck da Silva Etges AP; Tiscoski KA; de Lara LR; de Medeiros Zelmanowicz A; Polanczyk CA
Int J Technol Assess Health Care; 2021 Apr; 37(1):e60. PubMed ID: 33896428
[TBL] [Abstract][Full Text] [Related]
15. Moving the Brazilian ischaemic stroke pathway to a value-based care: introduction of a risk-adjusted cost estimate model for stroke treatment.
Etges APBDS; Marcolino MAZ; Ogliari LA; de Souza AC; Zanotto BS; Ruschel R; Safanelli J; Magalhães P; Diegoli H; Weber KT; Araki AP; Nunes A; Ponte Neto OM; Nabi J; Martins SO; Polanczyk CA
Health Policy Plan; 2022 Oct; 37(9):1098-1106. PubMed ID: 35866723
[TBL] [Abstract][Full Text] [Related]
16. Utilizing time-driven activity-based costing to understand the short- and long-term costs of treating localized, low-risk prostate cancer.
Laviana AA; Ilg AM; Veruttipong D; Tan HJ; Burke MA; Niedzwiecki DR; Kupelian PA; King CR; Steinberg ML; Kundavaram CR; Kamrava M; Kaplan AL; Moriarity AK; Hsu W; Margolis DJ; Hu JC; Saigal CS
Cancer; 2016 Feb; 122(3):447-55. PubMed ID: 26524087
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
